Published • loading... • Updated
Gene Editing at Scale, Clinic Seeks Generalizable Therapies
Ajay Gannerkote, president of Integrated DNA Technologies (IDT), says what’s most exciting about CRISPR is its potential to shift medicine from managing disease to directly correcting its root cause. “For patients with severe genetic conditions, especially those with no existing treatment options, that represents a fundamental change in what’s possible,” he said. IDT played a pivotal role in manufacturing the personalized gene editing therapy gi…
1 Articles
1 Articles
Gene Editing at Scale, Clinic Seeks Generalizable Therapies
Ajay Gannerkote, president of Integrated DNA Technologies (IDT), says what’s most exciting about CRISPR is its potential to shift medicine from managing disease to directly correcting its root cause. “For patients with severe genetic conditions, especially those with no existing treatment options, that represents a fundamental change in what’s possible,” he said. IDT played a pivotal role in manufacturing the personalized gene editing therapy gi…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
